title: Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes.
authors: Vikas
authors: V
authors: Bhalla
authors: Vasiliki V
authors: VV
authors: Georgiopoulou
authors: Ali A
authors: AA
authors: Azeem
authors: Catherine N
authors: CN
authors: Marti
authors: Robert T
authors: RT
authors: Cole
authors: Sonjoy R
authors: SR
authors: Laskar
authors: Christine
authors: C
authors: De Staercke
authors: W Craig
authors: WC
authors: Hooper
authors: Andrew L
authors: AL
authors: Smith
authors: Andreas P
authors: AP
authors: Kalogeropoulos
authors: Javed
authors: J
authors: Butler
mesh_terms: D018450:Disease Progression; D005260:Female; D006333:Heart Failure / Q000201:enzymology / Q000453:epidemiology / Q000503:physiopathology; D006801:Humans; D008297:Male; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D008875:Middle Aged; D009017:Morbidity / Q000639:trends; D011379:Prognosis; D015996:Survival Rate / Q000639:trends; D019714:Tissue Inhibitor of Metalloproteinases / Q000378:metabolism*; D014481:United States / Q000453:epidemiology; D020257:Ventricular Remodeling / Q000502:physiology*
chemical_list: D019714:Tissue Inhibitor of Metalloproteinases; D020782:Matrix Metalloproteinases